Brii Biosciences>   Coy Stout
Coy Stout
Coy Stout is a highly experienced professional with 29.5 years of work experience in the healthcare and pharmaceutical industry. Based in the United States, Coy Stout is currently working at Brii Biosciences, where they focus on gaining patient insights through partnerships and research. They specialize in improving access to care, prevention, and treatment for individuals with life-threatening conditions. Coy Stout is known for their expertise in patient insights, advocacy, policy, and solutions related to drug coverage, innovative payment models, US pricing, and patient support programs. They are also an experienced spokesperson with media and advocacy groups, representing corporate positioning on complex issues and strengthening relationships and corporate reputation. Coy Stout is passionate about social work education and leadership, focusing on applying anti-racist and .Read More

Coy Stout Contact information

Add to List
Sequence
Dialer

Coy Stout Current Workspace

Angela Work Summary

Number of Companies worked For
14
Average duration at company ( Year )
2
Number of job Positions
14

About Coy Stout

At Brii Biosciences, I focus on gaining patient insights through partnership and research to advance the development of new medications that truly address patient needs. I thrive on finding solutions to improve access to care, prevention, and treatment for individuals with life-threatening conditions. I have enjoyed building and leading teams in community-based settings, local & state public health, and the pharmaceutical industry with an emphasis on diversity and inclusion in the workplace. My expertise spans patient insights and advocacy, policy, and solutions related to drug coverage, innovative payment models, US pricing and distribution channels, and patient support programs. I am an experienced spokesperson with media and advocacy groups in representing corporate positioning on complex issues and strengthening relationships and corporate reputation. I have planned and led the access and reimbursement efforts for more than 30 product launches in the areas of COVID-19, HIV, Hepatitis B and C, Pulmonary Arterial Hypertension, Cystic Fibrosis, Ischemic Heart Disease, and Oncology. I am a passionate advocate for social work education and leadership as evidenced through my volunteer work and philanthropy with the University of Alabama School of Social Work. My personal development is focused on pursuing my doctorate of social work degree at Simmons University with an emphasis on applying anti-racist and anti-oppressive approaches to advancing social justice and health equity, including all LGBTQIA+ identities. .Read More

Coy Stout’s Activities

I was honored to join The RealPharma podcast with Ian Wendt and Dr. Na-Ri Oh to discuss the crucial role of patient advocacy in pharmaceutical innovation. It's essential to incorporate patient journeys across all aspects of the innovation process. The real credit goes to the patients, advocates, and allies who offer their insights, support, and partnership to advance new treatment options in areas of high unmet need and stigma. #PatientAdvocacy #PharmaceuticalInnovation #RealPharmaPodcast .Read More
March 06 2024
Show all activites

Coy Stout's Current Workspace

Brii Biosciences
Brii Biosciences2021-09-01 - Present
Brii Biosciences is a biotechnology company developing therapies to address some of the world’s most common public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas. With a focus on infectious diseases and central nervous system diseases, we have built a robust pipeline of potential treatment options based on patient insights and experiences, and are advancing these differentiated investigational therapies to address patient choice. Led by a visionary and experienced leadership team, Brii Bio has deep scientific expertise and a proven ability to progress therapeutic assets from discovery to commercial approval on a consolidated timeline. Established in 2018, Brii Bio now has operations in key biotech hubs, including Raleigh-Durham, the San Francisco Bay Area, Beijing and Shanghai. On July 13, 2021, the Company was officially listed on the Hong Kong Stock Exchange under the stock code 2137.HK. .Read More

Coy Stout's Work Experiance

  • Senior Vice President Head Of Patient Advocacy And Policy2022-09-01 - Present
    Brii Biosciences is a biotechnology company developing therapies to address some of the world’s most common public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas. With a focus on infectious diseases and central nervous system diseases, we have built a robust pipeline of potential treatment options based on patient insights and experiences, and are advancing these differentiated investigational therapies to address patient choice. Led by a visionary and experienced leadership team, Brii Bio has deep scientific expertise and a proven ability to progress therapeutic assets from discovery to commercial approval on a consolidated timeline. Established in 2018, Brii Bio now has operations in key biotech hubs, including Raleigh-Durham, the San Francisco Bay Area, Beijing and Shanghai. On July 13, 2021, the Company was officially listed on the Hong Kong Stock Exchange under the stock code 2137.HK. .Read More

    Location

    110 N Corcoran St, Durham, North Carolina, 27701, US

    Industry

    Biotechnology Research

    Employees